US2020339565A1PendingUtilityA1

Prodrug substituted polycyclic carbamoyl pyridone derivative

71
Assignee: SHIONOGI & COPriority: Sep 24, 2010Filed: Nov 15, 2019Published: Oct 29, 2020
Est. expirySep 24, 2030(~4.2 yrs left)· nominal 20-yr term from priority
Inventors:Chika TakahashiHidenori MikamiyamaToshiyuki AkiyamaKenji TomitaYoshiyuki TaodaMakoto KawaiKosuke AnanMasayoshi MiyagawaNaoyuki Suzuki
C07D 471/04A61P 31/00C07D 471/14A61K 31/541A61P 43/00A61K 31/53A61K 31/4738C07D 253/10A61P 31/16C07F 9/65616C07F 9/6561
71
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides a compound having antiviral effects, particularly having growth inhibitory activity on influenza viruses, a preferred example of the compound being a substituted 3-hydroxy-4-pyridone derivative prodrug having cap-dependent endonuclease inhibitory activity.

Claims

exact text as granted — not AI-modified
1 - 24 . (canceled) 
     
     
         25 . Use of Reference example 25 for treating a disease.

Join the waitlist — get patent alerts

Track US2020339565A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.